As Foroohar put it, Marks “was a driver of a lot of acceleration” for the cell and gene therapy space ... voluntary departures of reviewers, CMC staff, etc., the boots on the ground ...

Bengaluru: A collaboration between Biotechnology Research and Innovation Council's Institute for Stem Cell ... and CMC Vellore has resulted in the country's first human gene therapy trial for ...

The company was originally formed with a primary focus on the research of emerging classes of medicines like cell and gene therapies ... more seamlessly with CMC activities and manufacturing ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

It’s no wonder the cell and gene therapy ... such as flow cytometry and droplet digital polymerase chain reaction tests, to measure the genetic vector over time, including how a therapy is ...

In this article, we will be taking a look at the 11 best gene therapy stocks to buy according to analysts. Gene therapy is a medical approach that entails changing or modifying genes to treat or ...

The hope is that the gene therapy could provide the first alternative to allogeneic haematological stem cell transplantation ... and controls (CMC) data. The company also has two phase 2 trials ...

Digital Global Systems (DGS), a leader in AI-powered spectrum and sensor intelligence, announced today a major milestone in the expansion of its patent portfolio. DGS now holds the largest number of U ...

Flow cytometers. Genomics. Particle counters/analyzers ... supporting applications such as UCAR-T cell therapy. For gene therapy, we offer MaxNuclease to eliminate contaminants like host DNA and ...

For decades, cystic fibrosis has remained a relentless, life-limiting disease. But now, the future of cystic fibrosis care could be shifting from symptom management to something far more revolutionary ...